Profil
Florence Alouch is the founder and former Chief Executive Officer of SparingVision SAS, which was founded in 2016.
Currently, she is the Chairman-Supervisory Board at Génomic Vision SA since 2022.
Ms. Alouch holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Universite Paris Cite.
Aktive Positionen von Florence Alouch
| Unternehmen | Position | Beginn |
|---|---|---|
| GENOMIC VISION | Vorsitzender | 11.07.2022 |
Ehemalige bekannte Positionen von Florence Alouch
| Unternehmen | Position | Ende |
|---|---|---|
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Vorstandsvorsitzender | - |
Ausbildung von Florence Alouch
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| Universite Paris Cite | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENOMIC VISION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Health Technology |
